Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Wyrwicz, L.S.
96  Ergebnisse:
Personensuche X
?
1

397MO Tislelizumab (TIS) plus chemotherapy (CT) vs placebo ..:

Moehler, M. ; Oh, D-Y. ; Kato, K....
Annals of Oncology.  35 (2024)  - p. S160-S161 , 2024
Link: https://doi.org/10.1016/..
 
?
2

7P Feasibility, toxicity and clinical outcomes of carboplat..:

Temnyk, M. ; Pędziwiatr, K. ; Gidzińska-Wielgosz, M..
ESMO Open.  9 (2024)  - p. 102399 , 2024
Link: https://doi.org/10.1016/..
 
?
3

399P A Quality-adjusted Time Without Symptoms and Toxicity ..:

Chau, I. ; Bridgewater, J.A. ; Wyrwicz, L.S....
Annals of Oncology.  35 (2024)  - p. S162 , 2024
Link: https://doi.org/10.1016/..
 
?
4

395MO Tislelizumab (TIS) + chemotherapy (CT) vs placebo (PB..:

Raymond, E. ; Xu, J. ; Kato, K....
Annals of Oncology.  35 (2024)  - p. S159 , 2024
Link: https://doi.org/10.1016/..
 
?
5

398P Nivolumab (NIVO) plus chemotherapy (chemo) or ipilimum..:

Adenis, A. ; Chau, I. ; Ajani, J.A....
Annals of Oncology.  35 (2024)  - p. S161-S162 , 2024
Link: https://doi.org/10.1016/..
 
?
6

LBA3 Final analysis of the phase III KEYNOTE-585 study of p..:

Shitara, K. ; Rha, S.Y. ; Wyrwicz, L.S....
Annals of Oncology.  35 (2024)  - p. S213 , 2024
Link: https://doi.org/10.1016/..
 
?
7

419P Nivolumab (NIVO) + chemotherapy (chemo) vs chemo as fi..:

Wyrwicz, L.S. ; Shitara, K. ; Moehler, M....
Annals of Oncology.  35 (2024)  - p. S169-S170 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Detecting reliable non interacting proteins (NIPs) signific..:

Srivastava, A. ; Mazzocco, G. ; Kel, A...
Molecular BioSystems.  12 (2016)  3 - p. 778-785 , 2016
Link: https://doi.org/10.1039/..
 
?
9

The distribution of human endogenous retrovirus K-113 in he..:

Krzysztalowska-Wawrzyniak, M. ; Ostanek, M. ; Clark, J....
Rheumatology.  50 (2011)  7 - p. 1310-1314 , 2011
Link: https://doi.org/10.1093/..
 
?
10

AutoMotif server: prediction of single residue post-transla..:

Plewczynski, D. ; Tkacz, A. ; Wyrwicz, L. S..
Bioinformatics.  21 (2005)  10 - p. 2525-2527 , 2005
Link: https://doi.org/10.1093/..
 
?
11

Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in..:

Shitara, Kohei ; Rha, Sun Young ; Wyrwicz, Lucjan S...
The Lancet Oncology.  25 (2024)  2 - p. 212-224 , 2024
Link: https://doi.org/10.1016/..
 
?
12

Pembrolizumab plus chemotherapy versus placebo plus chemoth..:

Rha, Sun Young ; Oh, Do-Youn ; Yañez, Patricio...
The Lancet Oncology.  24 (2023)  11 - p. 1181-1195 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Pembrolizumab plus trastuzumab and chemotherapy for HER2-po..:

Janjigian, Yelena Y ; Kawazoe, Akihito ; Bai, Yuxian...
The Lancet.  402 (2023)  10418 - p. 2197-2208 , 2023
Link: https://doi.org/10.1016/..
 
?
14

The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER..:

Janjigian, Yelena Y. ; Kawazoe, Akihito ; Yañez, Patricio...
Nature.  600 (2021)  7890 - p. 727-730 , 2021
Link: https://doi.org/10.1038/..
 
?
15

High-density Peptide Arrays Help to Identify Linear Immunog..:

Jaenisch, Thomas ; Heiss, Kirsten ; Fischer, Nico...
Molecular & Cellular Proteomics.  18 (2019)  4 - p. 642-656 , 2019
Link: https://doi.org/10.1074/..
 
1-15